Acute Kidney Injury Clinical Trial
Official title:
The Furosemide Stress Test, Electrolytes Response and Renal Index in Critically Ill Patients
Aim of the present study is to compare the response to furosemide stress test in term of diuresis and electrolytes and of the renal index in mechanically ventilated patients at admission and after 3 days in patients with and without the presence of AKI
The acute kidney injury (AKI) is a common clinical syndrome in critically ill patients,
occurring in up of 60% of the patients, and almost 40% of these patients will die within 90
days . Between 5% to 10% of the patients with AKI requires renal replacement therapy and only
30% will be alive after 5 years . The most common reported contributing factors to AKI were
sepsis, major surgery, cardiogenic shock, hypovolemia and potentially related drugs .
Although the AKI has been classically defined as an abrupt and sustained decrease in renal
function and is commonly assessed on serum creatinine rise and/or fall in urine output there
are not clear cutoffs for the diagnosis . Unfortunately the changes in these two parameters
are poor predicting of AKI in critically ill patients . In the recent years several renal
biomarkers have been proposed to accurately detect acute tubular injury before serum
creatinine changes with possible improvement in the outcome; however the evidence was quite
low . Because the majority of early AKI are related to an acute tubular injury, it has been
suggested to evaluate the tubular function reserve by a bolus of furosemide (i.e. the
furosemide stress test). As an organic acid, furosemide is tightly bound to serum proteins
and gains access to the tubular urinary space through active secretion in the proximal
convoluted tubule via the human organic anion transporter system .Once in the tubular lumen,
furosemide inhibits chloride transport throughout the thick ascending limb of Henle,
preventing sodium reabsorption: this results in natriuresis, increased urine flow and
potentially reduced tubular oxygen demand . Specially a relatively intact kidney, with
preserved estimated glomerular filtration rate (eGFR) and tubular function, should respond to
furosemide with a quick diuresis, whereas tubular injury can be associated with urine output
that is relatively preserved at baseline, but that fails to significantly augment with a
diuretic challenge. In one mixed (retrospective and prospective) study and in one randomized
trial in critically ill patients admitted in intensive care with mild AKI, the furosemide
stress test was able to predict the progression to severe AKI. Furthermore also the response
to electrolyte excretion should predict the possible presence of AKI . In addition the renal
imaging techniques by ultrasound, which are non invasive and repeatable, are considered a
mandatory component of the AKI diagnostic work up . Among the available imaging technique the
renal resistive index (RI) which compute the ratio between the systolic and diastolic blood
velocity in the arcuate or interlobular arteries is the most common used due to the easiness
and to the good reproducibility . Although the physiological and clinical significance of RI
is still debated because is related to the resistance and compliance of the renal vessels and
to the central hemodynamic , previous studies have shown the utility of RI to predict both
the occurrence and the reversibility of AKI .
Aim of the present study is to compare the response to furosemide stress test in term in
diuresis and electrolytes and of the renal index in mechanically ventilated patients at
admission and after 3 days in patients with and without the presence of AKI
All consecutive mechanically ventilated patients, following an hemodynamic stabilization
(mean arterial pressure of at least 65 mmHg without the need for fluid bolus and/or start or
increase in the dose of vasopressors or inotropic drugs within the last 6 h), admitted to the
General Intensive Care of Santi Paolo-Carlo Hospital were enrolled. Exclusion criteria were:
an age < 18 years, pregnancy, hemodynamic instability (defined as mean arterial pressure
(MAP)<60 mmHg), a suspected or confirmed obstructive renal failure, the presence of a chronic
renal failure, as defined by a basal creatinine clearance value < 30 ml min-1 . During the
study the level of sedation and the ventilatory setting were not changed.
Renal index
The renal index examination was performed by one among three dedicated physicians, who were
not in charge of the patients and trained with ultrasound examinations . Doppler
ultrasonography will be performed at the patient's bedside by the same trained operator using
an ultrasound scanner (LogiQ7 General Electric Healthcare, UK) with a 5 Mega-hertz
transducer. The Doppler measurements will be obtained from the right kidney in all patient.
After visualization of the kidney in gray scale and color Doppler modes, the absence of signs
of chronic renal damage will be checked. The interlobar or arcuate arteries will be localized
with sonography and color Doppler mode. Blood velocities in the interlobar arteries will be
recorded using pulse-wave Doppler. RI will be calculated as follow:
RI= (Peak Systolic velocity - end Diastolic Velocity)/Peak systolic velocity and average.
At least three readings will be obtained from the selected arteries, and the mean of the
corresponding three renal RI determinations will be used for the study
Furosemide stress test After the ultrasonography evaluation, the patients will be tested with
the Furosemide Stress Test (FST). Who will be loop-diuretic naïve will be given 1.0 mg/kg of
intravenous furosemide. Because patients who are previously treated with loop diuretics
within the previous 7 days are likely to have a blunted response over time compared to naïve
patients, this group will receive an intravenous dose of 1.5 mg/kg) . In order to minimize
the risk of hypovolemia, urine output will be replaced ml for ml each hour with Ringers
lactate for six hours after the FST.
Data collection Before and after two hours of the renal index and the furosemide stress text
the following clinical and laboratory data were collected: mean arterial pressure, central
venous pressure, heart rate, plasma and urine amount of sodium, potassium, chloride, and
arterial blood gas analysis. The urine volume was measured after one and two hours
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05538351 -
A Study to Support the Development of the Enhanced Fluid Assessment Tool for Patients With Acute Kidney Injury
|
||
| Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
| Completed |
NCT03938038 -
Guidance of Ultrasound in Intensive Care to Direct Euvolemia
|
N/A | |
| Recruiting |
NCT05805709 -
A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial
|
N/A | |
| Recruiting |
NCT05318196 -
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
|
||
| Recruiting |
NCT05897840 -
Continuous Central Venous Oxygen Saturation Measurement as a Tool to Predict Hemodynamic Instability Related to Renal Replacement Therapy in Critically Ill Patients
|
N/A | |
| Recruiting |
NCT04986137 -
Fractional Excretion of Urea for the Differential Diagnosis of Acute Kidney Injury in Cirrhosis
|
||
| Terminated |
NCT04293744 -
Acute Kidney Injury After Cardiac Surgery
|
N/A | |
| Completed |
NCT04095143 -
Ultrasound Markers of Organ Congestion in Severe Acute Kidney Injury
|
||
| Not yet recruiting |
NCT06026592 -
Detection of Plasma DNA of Renal Origin in Kidney Transplant Patients
|
||
| Not yet recruiting |
NCT06064305 -
Transcriptional and Proteomic Analysis of Acute Kidney Injury
|
||
| Terminated |
NCT03438877 -
Intensive Versus Regular Dosage For PD In AKI.
|
N/A | |
| Terminated |
NCT03305549 -
Recovery After Dialysis-Requiring Acute Kidney Injury
|
N/A | |
| Completed |
NCT05990660 -
Renal Assist Device (RAD) for Patients With Renal Insufficiency Undergoing Cardiac Surgery
|
N/A | |
| Completed |
NCT04062994 -
A Clinical Decision Support Trial to Reduce Intraoperative Hypotension
|
||
| Terminated |
NCT02860130 -
Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)
|
Phase 3 | |
| Completed |
NCT06000098 -
Consol Time and Acute Kidney Injury in Robotic-assisted Prostatectomy
|
||
| Not yet recruiting |
NCT05548725 -
Relation Between Acute Kidney Injury and Mineral Bone Disease
|
||
| Completed |
NCT02665377 -
Prevention of Akute Kidney Injury, Hearttransplant, ANP
|
Phase 3 | |
| Terminated |
NCT03539861 -
Immunomodulatory Biomimetic Device to Treat Myocardial Stunning in End-stage Renal Disease Patients
|
N/A |